Biotechnology - Samsung BioLogics

Filter

Current filters:

Samsung BioLogics

Popular Filters

Bristol-Myers partners with South Korean firm on biopharma production

29-07-2013

US pharma major Bristol-Myers Squibb (NYSE: BMY) has entered into a 10-year agreement under which Samsung…

Asia-PacificBiotechnologyBristol-Myers SquibbOncologyPharmaceuticalProductionSamsung BioLogics

Parexel

Parexel

Back to top